Predictors of immune-related adverse events and outcomes in patients with NSCLC treated with immune-checkpoint inhibitors.
Autores da FMUP
Participantes de fora da FMUP
- Serino, M
- Martins, M
- Cardoso, C
- Veiga, F
- Santos, V
- Araújo, D
- Magalhaes, A
- Queiroga, H
Unidades de investigação
Abstract
Filiações
Filiações não disponíveis
Proyectos asociados
Fibrosing ILD Biomarkers That Rule Acceleration (FIBRALUNG) -NCT05635032
Investigador Principal: Hélder Novais e Bastos
Estudo Observacional Académico (FIBRALUNG) . FCT . 2021
MCP1 as a prognostic biomarker in Hypersensitivity Pneumonitis: a prospective study
Investigador Principal: Hélder Novais e Bastos
Estudo Clínico Académico (Pneumonitis) . 2023
Doença do Refluxo Gastro-esofágico e Doença Pulmonar
Investigador Principal: Venceslau José Coelho Pinto Hespanhol
Estudo Clínico Académico (Refluxo Gastro-esofágic) . 2020
A importância do diagnóstico na Fibrose Pulmonar Idiopática
Investigador Principal: Venceslau José Coelho Pinto Hespanhol
Estudo Clínico Académico (FPI) . 2020
Chronic Bronchopulmonary aspergillosis patients with underlying chronic obstructive pulmonary disease: providing grounds for biomarkers search through clinical phenotyping
Investigador Principal: Hélder Novais e Bastos
Estudo Clínico Académico . 2020
Impact of Chronic Obstructive Pulmonary Disease in surgical outcomes of lung cancer patients undergoing curative intent surgery
Investigador Principal: Hélder Novais e Bastos
Estudo Clínico Académico . 2021
Pulmonary Emphysema Regional Distribution and Extent from Chest Computed Tomography is Associated with Pulmonary Function Impairment in COPD Patients.
Investigador Principal: Hélder Novais e Bastos
Estudo Clínico Académico . 2021
Non-invasive assessment of Benign Tracheal Stenosis.
Investigador Principal: Hélder Novais e Bastos
Estudo Clínico Académico . 2020
Imunoterapia no cancro do pulmão: PD-L1, biomarcador preditivo?
Investigador Principal: Venceslau José Coelho Pinto Hespanhol
Estudo Clínico Académico . 2020
Predictors of lung entrapment in malignant pleural effusion
Investigador Principal: Hélder Novais e Bastos
Estudo Clínico Académico . 2022
Influência de Polimorfismos Genéticos e da Biologia Tumoral no Comportamento do Cancro do Pulmão
Investigador Principal: Venceslau José Coelho Pinto Hespanhol
Estudo Clínico Académico . 2023
Breastfeeding, industry marketing and migration in the era of Globalization
Investigador Principal: Cláudia Susana Soares de Freitas
Estudo Clínico Académico . 2023
Citar a publicação
Serino M,Freitas C,Martins M,Ferreira P,Cardoso C,Veiga F,Santos V,Araújo D,Novais H,Magalhaes A,Queiroga H,Fernandes G,Hespanhol V. Predictors of immune-related adverse events and outcomes in patients with NSCLC treated with immune-checkpoint inhibitors. Pulmonology. 2024. 30. (4):p. 352-361. IF:11,700. (1).